Drive adoption of QUELIMMUNE for ultra-rare pediatric AKI, expanding revenue and doubling the customer base Advance SeaStar Medical's first-in-class SCD therapy for the adult AKI indication - a potent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback